Trastuzumab dkst price?

See the DrugPatentWatch profile for Trastuzumab

Current Cost of Trastuzumab Injection (DKT)

Trastuzumab Injection (DKT), also known as Herceptin, is a medication used to treat certain types of breast cancer. The cost of Trastuzumab can vary depending on the location, pharmacy, and specific requirements of the patient.

In the United States, the list price for Trastuzumab Injection is around $3,800 – $5,800 per dose, with a typical treatment course costing around $50,000 – $90,000 [1] from a reference price in 2023. However, actual prices can differ and may be higher for patients without adequate insurance coverage.

Cost Comparison and Discounts

When comparing prices, it's essential to consider the cost of the medication, administration fees, and any applicable discounts or patient assistance programs. Some companies or online resources might offer lower prices or special deals for patients who meet certain criteria.

Patient Assistance Programs

Drug manufacturers sometimes provide patient assistance programs, which can help reduce the financial burden for eligible patients. These programs may cover some or all of the medication costs, although specifics vary depending on the manufacturer and the individual's situation.

Generic Alternative

While there isn't a direct generic alternative to Trastuzumab, biosimilar versions like Adjuvante (trastuzumab) and Trazimera are available, offering a more affordable option for some patients [2].

Regulatory Information

As of my knowledge cutoff in 2023, there is limited information on changes to the patent status or pricing of Trastuzumab Injection. Patent expiration might affect the availability of biosimilar or generic versions, which could potentially reduce prices.

Sources:

[1] - Centers for Medicare & Medicaid Services (US).
[2] - drugpatentwatch.com ( Biosimilar versions)